Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 5, 2026
Minimally Invasive Partial versus Radical Nephrectomy for Non-metastatic pT3a Renal Cell Carcinoma: a Multicenter Matched Cohort Study
Xiangpeng Zou, Zhenhua Liu, Yunhan Luo, et al.
Cell Reports. Medicine
|
December 28, 2023
Extraperitonealization of the ileal conduit decreases the risk of parastomal hernia: A single-center, randomized clinical trial
Zhaohui Zhou, Longbin Xiong, Kai Yao, et al.
BMC Nephrology
|
July 9, 2016
RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
Zongshun Huang, Li Zhang, Yuanhan Chen, et al.
European Radiology
|
December 20, 2022
Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study
Jun Wang, Pei Dong, Yuanyuan Qu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study
Longbin Xiong, Xingli Shan, Huali Ma, et al.
Cell Communication and Signaling : CCS
|
July 2, 2026
A pan-cancer single-cell atlas uncovers the role of sex hormones and chromosomes in sex-divergent reprogramming of the tumor microenvironment
Zhenyu Luo, Haoran Shi, Yingyi Shan, et al.
Frontiers in Medicine
|
December 22, 2025
Comparative study of eGFR in cancer and non-cancer individuals: a multicenter analysis
Baokui Ye, Xin Luo, Yunhan Luo, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
Journal of Evidence-Based Medicine
|
December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)
Zhiling Zhang, Pengxiang Zhou, Na He, et al.
European Urology
|
January 21, 2022
What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
Longbin Xiong, Jane K Nguyen, Yulu Peng, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 5, 2026
Minimally Invasive Partial versus Radical Nephrectomy for Non-metastatic pT3a Renal Cell Carcinoma: a Multicenter Matched Cohort Study
Xiangpeng Zou, Zhenhua Liu, Yunhan Luo, et al.
Cell Reports. Medicine
|
December 28, 2023
Extraperitonealization of the ileal conduit decreases the risk of parastomal hernia: A single-center, randomized clinical trial
Zhaohui Zhou, Longbin Xiong, Kai Yao, et al.
BMC Nephrology
|
July 9, 2016
RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
Zongshun Huang, Li Zhang, Yuanhan Chen, et al.
European Radiology
|
December 20, 2022
Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study
Jun Wang, Pei Dong, Yuanyuan Qu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study
Longbin Xiong, Xingli Shan, Huali Ma, et al.
Cell Communication and Signaling : CCS
|
July 2, 2026
A pan-cancer single-cell atlas uncovers the role of sex hormones and chromosomes in sex-divergent reprogramming of the tumor microenvironment
Zhenyu Luo, Haoran Shi, Yingyi Shan, et al.
Frontiers in Medicine
|
December 22, 2025
Comparative study of eGFR in cancer and non-cancer individuals: a multicenter analysis
Baokui Ye, Xin Luo, Yunhan Luo, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
Journal of Evidence-Based Medicine
|
December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)
Zhiling Zhang, Pengxiang Zhou, Na He, et al.
European Urology
|
January 21, 2022
What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
Longbin Xiong, Jane K Nguyen, Yulu Peng, et al.
Page
of 21